KHADIAN SMITH: Open Payments
NPI 1629531108 · BLUE BELL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 22 payments from 5 companies in 2025. Trend: 2023 $854 · 2024 $838 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $199 |
| AstraZeneca Pharmaceuticals LP | 7 | $135 |
| Novo Nordisk Inc | 2 | $48 |
| Lilly USA, LLC | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
Products named: VRAYLAR, AIRSUPRA, UBRELVY, BREZTRI, MOUNJARO, AUSTEDO XR, FARXIGA, Rybelsus.
Industry payments across PA — which companies pay providers there.
